QWM
GILD icon

Quadcap Wealth Management’s Gilead Sciences GILD Stock Holding History

Quadcap Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Sell
2,249
-2,669
-54% -$352K 0.03% 345
2026
Q1 		$685K Sell
4,918
-141
-3% -$19.7K 0.08% 215
2025
Q4 		$621K Sell
5,059
-13
-0.3% -$1.58K 0.07% 229
2025
Q3 		$563K Sell
5,072
-30
-0.6% -$3.41K 0.07% 244
2025
Q2 		$566K Buy
5,102
+1,009
+25% +$107K 0.07% 242
2025
Q1 		$459K Buy
+4,093
New +$422K 0.07% 249

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quadcap Wealth Management's GILD Position: Q2 2026 in Review

Quadcap Wealth Management reduced its Gilead Sciences (GILD) stake by 54% in Q2 2026, selling an estimated $352K and leaving 2,249 shares worth $284K. The position accounts for 0.03% of the portfolio, ranked #345.

Quadcap Wealth Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $685K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Quadcap Wealth Management held 2,249 shares of Gilead Sciences worth $284K as of Q2 2026.
  • Quadcap Wealth Management sold 2,669 Gilead Sciences shares in Q2 2026, an estimated $352K.
  • Gilead Sciences made up 0.03% of Quadcap Wealth Management's portfolio in Q2 2026, its #345 holding.
  • Quadcap Wealth Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Quadcap Wealth Management's Gilead Sciences position peaked at $685K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.